Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

ESMO Asia 2017 - Industry satellite symposium

print
PRINT
insite
SEARCH

Chaired by Ian Chau with Jae-Ho Cheong, Eva Segelov, and Kohei Shitara​​​​​​​

Held on Friday 17th November at the Suntec Singapore Convention and Exhibition Centre

This industry satellite symposium discussed the latest in gastric cancer treatment and molecular analysis, and provided advice on how to incorporate the ever-changing current optimal therapeutic strategies into everyday clinical practice, using case presentations to stimulate interactive discussion. We hope that by sharing expert experience and perspectives, it can help navigate the complexities of gastric cancer care and provide you with knowledge that you will be able to seamlessly apply to your own clinical practice.

Scientific summary 

© Springer Healthcare IME​​​​​​​

print
PRINT